Filter
624
Filtered Results: 624
Text search:
Kumar,
R.
Featured
Recommendations
62
New Publications
141
Language
Document type
No document type
336
Studies & Reports
111
Guidelines
106
Manuals
32
Fact sheets
16
Strategic & Response Plan
11
Training Material
8
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
123
Nepal
32
Global
24
Bangladesh
11
Asia
11
Brazil
10
Russia
9
Germany
7
Western and Central Europe
7
Kenya
5
Indonesia
4
South Africa
4
Mozambique
4
Colombia
4
Middle East and North Africa
4
South–East Asia Region
4
Eastern Europe
4
Thailand
3
Malawi
3
Ukraine
3
Ecuador
3
Lesotho
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Guinea
2
Sierra Leone
2
Liberia
2
Guinea-Bissau
2
Ethiopia
2
Cameroon
2
Zambia
2
Benin
2
Angola
2
Myanmar / Burma
2
Sri Lanka
2
West and Central Africa
2
Western Pacific Region
2
Latin America and the Carribbean
2
Africa
2
Timor Leste/ East Timor
2
Burkina Faso
1
Nigeria
1
Ghana
1
Uganda
1
Zimbabwe
1
Philippines
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Tanzania
1
China
1
Sudan
1
Argentina
1
Yemen
1
Other region
1
Bhutan
1
Venezuela
1
North Korea
1
Tajikistan
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
222
Clinical Guidelines
84
Public Health
50
Women & Child Health
32
Key Resources
21
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
TB
82
COVID-19
72
Mental Health
35
Caregiver
34
Disability
28
HIV
26
NTDs
24
Planetary Health
23
NCDs
15
AMR
12
Refugee
10
Pharmacy
9
Natural Hazards
7
Rapid Response
7
Polio
6
Global Health Education
6
Health Financing Toolbox
5
Ebola
3
Cholera
2
Specific Hazards
2
Conflict
1
Social Ethics
1
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
Guidance for addressing a global infodemic and fostering demand for immunization
December 2020
Misinformation threatens the success of vaccination programs across the world. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordina...
Orientations pour faire face à une infodémie mondiale et favoriser la demande de vaccination
Décembre 2020
La désinformation menace le succès des programmes de vaccination dans le monde entier. Ce guide vise à aider les organisations à faire face à l'infodémie mondiale par l'élaboration ...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Interim guidance 2 February 2021 . Available in Arabic, Chinese, English, French, Ukranian, Russian
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-CoV-2 and othe...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
National Essential Diagnostic List
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit...
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit...
based on information as at 28 February 2021
Rapid Policy Brief Series Series 14: COVID-19 and hypertension
